CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials. - Beshr MS; Fahaid A; Shembesh RH; Valachis A; Lambertini M; Cortesi L; Alesawy AF; Abraheem A; Alsharedi M; Ali ME; Elkhanany A; Azim HA Jr; et al. (The Lancet. Oncology, 2026)